Epitomee Medical Valuation

Is EPIT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EPIT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate EPIT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate EPIT's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EPIT?

Key metric: As EPIT is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for EPIT. This is calculated by dividing EPIT's market cap by their current earnings.
What is EPIT's PE Ratio?
PE Ratio	28.8x
Earnings	US$2.66m
Market Cap	US$76.68m

EPIT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.6x
Enterprise Value/EBITDA	7.1x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does EPIT's PE Ratio compare to its peers?

The above table shows the PE ratio for EPIT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	46.4x
BWAY BrainsWay	127x	63.6%	₪695.1m
BIOV Bio-View	36.4x	n/a	₪32.3m
NISA Nissan Medical Industries	7.7x	n/a	₪150.3m
GOHO Golden House	14.5x	n/a	₪320.0m
EPIT Epitomee Medical	28.8x	n/a	₪279.9m

Price-To-Earnings vs Peers: EPIT is good value based on its Price-To-Earnings Ratio (28.8x) compared to the peer average (46.4x).

Price to Earnings Ratio vs Industry

How does EPIT's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: EPIT is expensive based on its Price-To-Earnings Ratio (28.8x) compared to the Asian Medical Equipment industry average (25.7x).

Price to Earnings Ratio vs Fair Ratio

What is EPIT's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EPIT PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	28.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate EPIT's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.